LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 765 | 528 | 3124 | 0.1691 | -0.1003 |
Hs 578T | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 765 | 1028 | 3124 | 0.3291 | 0.1116 |
Hs 578T | GSK1904529A | 3.33 | uM | LJP6 | 72 | hr | 765 | 2849 | 3124 | 0.9120 | 0.8835 |
Hs 578T | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 765 | 405 | 3124 | 0.1297 | -0.1525 |
Hs 578T | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 765 | 2076 | 3124 | 0.6646 | 0.5559 |
Hs 578T | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 765 | 392 | 3124 | 0.1256 | -0.1580 |
Hs 578T | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 765 | 894 | 3124 | 0.2862 | 0.0548 |
Hs 578T | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 765 | 2620 | 3124 | 0.8385 | 0.7862 |
Hs 578T | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 765 | 3256 | 3124 | 1.0421 | 1.0557 |
Hs 578T | JNK-9L | 3.33 | uM | LJP6 | 72 | hr | 765 | 863 | 3124 | 0.2762 | 0.0415 |
Hs 578T | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 765 | 1466 | 3124 | 0.4693 | 0.2972 |
Hs 578T | Lapatinib | 3.33 | uM | LJP6 | 72 | hr | 765 | 3033 | 3124 | 0.9707 | 0.9612 |
Hs 578T | LDN-193189 | 3.33 | uM | LJP5 | 72 | hr | 765 | 1493 | 3124 | 0.4778 | 0.3085 |
Hs 578T | Linifanib | 3.33 | uM | LJP6 | 72 | hr | 765 | 2958 | 3124 | 0.9468 | 0.9296 |
Hs 578T | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 3097 | 3124 | 0.9914 | 0.9886 |
Hs 578T | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 765 | 189 | 3124 | 0.0606 | -0.2440 |
Hs 578T | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 765 | 212 | 3124 | 0.0681 | -0.2341 |
Hs 578T | MK2206 | 3.33 | uM | LJP6 | 72 | hr | 765 | 2014 | 3124 | 0.6446 | 0.5293 |
Hs 578T | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 1654 | 3124 | 0.5295 | 0.3769 |
Hs 578T | Nilotinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 3516 | 3124 | 1.1253 | 1.1659 |
Hs 578T | Nintedanib | 3.33 | uM | LJP6 | 72 | hr | 765 | 1601 | 3124 | 0.5125 | 0.3544 |
Hs 578T | NU7441 | 3.33 | uM | LJP5 | 72 | hr | 765 | 1975 | 3124 | 0.6323 | 0.5131 |
Hs 578T | Dactolisib | 3.33 | uM | LJP5 | 72 | hr | 765 | 853 | 3124 | 0.2732 | 0.0376 |
Hs 578T | NVP-TAE684 | 3.33 | uM | LJP6 | 72 | hr | 765 | 891 | 3124 | 0.2852 | 0.0534 |
Hs 578T | Palbociclib | 3.33 | uM | LJP6 | 72 | hr | 765 | 1511 | 3124 | 0.4838 | 0.3164 |